Weight gain in patients with schizophrenia and schizoaffective disorder induced by the long-term treatment with atypical antipsychotics

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 108, Issue 9, 2008, Pages 52-56

  Gorobets, L N ^a  

^a NONE

Author keywords

Atypical antipsychotics; Body mass index; Gender factor; Weight gain

Indexed keywords

EID: 54249094207     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Russian source
2. Russian source
3. Russian source
4. Russian source
5. Russian source
6. Russian source
7. Russian source
8. Russian source
9. Russian source
10. Russian source
11. Allison D.B., Fontaine K.R., Heo M. et al. The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiat 1999; 60: 215-220.
12. Allison D.B., Mentor J.M., Heo M. et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiat 1999; 156: 11: 1686-1696.
13. Bai Y.M., Lin C.C., Chen J.Y. et al. Weight gain among patients on clozapine. Psychiatr Serv 1999; 50: 704-705.
14. Bernstein J. G. Induction of obesity by psychotropic drugs. Ann NY Acad Sci 1987; 499: 203-215.
15. Bustillo J.R., Buchanan R. W., Irish D., Breier A. Differential effect of clozapine on weight: a controlled study. Am J Psychiat 1996; 153: 817-819.
16. Green J.K., Goisman R.M. et al. Weight Gain From Novel Antypsychotic Drugs: Need For Action. General Hospital Psychiatry 2000; 22: 224-235.
17. Kinon B.J., Basson B.R. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia. J Clin Psychiat 2001; 62: 92-100.
18. Masand P.S., Blackburn C.L., Ganguli R. et al. Weight gain associated with the use of anti psychotic medications. J Clin Psychiat 1999; Audiograph Series 2.
19. Newcomes J. W., Haupt D. W. The metabolic effects of antipsychotic medications. Can J Psychiat 2006; 51: 8: 480-491.
20. Tandon R., Halbreich U. The second-generation « atypical» antipsychotics: similar improved efficacy but different neuroendocrine side effects. Psychoneuroendocrinology 2003; 28: Suppl 1: 1-7.